AU782880B2 - High order nucleic acid based structures - Google Patents

High order nucleic acid based structures Download PDF

Info

Publication number
AU782880B2
AU782880B2 AU20001/01A AU2000101A AU782880B2 AU 782880 B2 AU782880 B2 AU 782880B2 AU 20001/01 A AU20001/01 A AU 20001/01A AU 2000101 A AU2000101 A AU 2000101A AU 782880 B2 AU782880 B2 AU 782880B2
Authority
AU
Australia
Prior art keywords
nucleic acid
molecules
poly
molecule
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20001/01A
Other languages
English (en)
Other versions
AU2000101A (en
Inventor
Frank J Carr
Graham Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926810.4A external-priority patent/GB9926810D0/en
Priority claimed from GB0011126A external-priority patent/GB0011126D0/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2000101A publication Critical patent/AU2000101A/en
Application granted granted Critical
Publication of AU782880B2 publication Critical patent/AU782880B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/52—Physical structure branched

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU20001/01A 1999-11-13 2000-11-13 High order nucleic acid based structures Ceased AU782880B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9926810 1999-11-13
GBGB9926810.4A GB9926810D0 (en) 1999-11-13 1999-11-13 High order nucleic acid-based structures
GB0011126 2000-05-10
GB0011126A GB0011126D0 (en) 2000-05-10 2000-05-10 High order nucleic acid-based structures
PCT/EP2000/011197 WO2001036624A1 (en) 1999-11-13 2000-11-13 High order nucleic acid based structures

Publications (2)

Publication Number Publication Date
AU2000101A AU2000101A (en) 2001-05-30
AU782880B2 true AU782880B2 (en) 2005-09-08

Family

ID=26244234

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20001/01A Ceased AU782880B2 (en) 1999-11-13 2000-11-13 High order nucleic acid based structures

Country Status (16)

Country Link
EP (1) EP1228201A1 (zh)
JP (1) JP2003522524A (zh)
KR (1) KR20020059727A (zh)
CN (1) CN1390253A (zh)
AU (1) AU782880B2 (zh)
BR (1) BR0015484A (zh)
CA (1) CA2391084A1 (zh)
CZ (1) CZ20021472A3 (zh)
HK (1) HK1052529A1 (zh)
HU (1) HUP0203914A2 (zh)
MX (1) MXPA02004727A (zh)
NO (1) NO20022231D0 (zh)
PL (1) PL358811A1 (zh)
RU (1) RU2002113755A (zh)
SK (1) SK6042002A3 (zh)
WO (1) WO2001036624A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
SG10201606482TA (en) 2011-08-05 2016-10-28 Harvard College Compositions and methods relating to nucleic acid nano-and micro-technology
US10604543B2 (en) 2012-07-24 2020-03-31 President And Fellows Of Harvard College Self-assembly of nucleic acid nanostructures
WO2014074597A1 (en) 2012-11-06 2014-05-15 President And Fellows Of Harvard College Compositions and methods relating to complex nucleic acid nanostructures
WO2015070080A2 (en) * 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Nucleic acid nanostructures for in vivo agent delivery
CN106488883A (zh) 2014-05-22 2017-03-08 哈佛学院院长及董事 可扩展的基于核酸的纳米制造
US11414694B2 (en) 2016-03-11 2022-08-16 Children's Medical Center Corporation Nucleic acid nanoswitch catenanes
CN115948505A (zh) 2016-08-02 2023-04-11 哈佛学院院长及董事 交叉协同自组装体
CN110711254B (zh) * 2018-07-12 2022-07-26 百药智达（北京）纳米生物技术有限公司 核酸纳米颗粒及包含其的药物组合物
KR102656600B1 (ko) * 2018-07-12 2024-04-15 바이 야오 쥐 다 (베이징) 나노바이오 테크놀로지 컴퍼니 리미티드 핵산 나노입자, 이를 포함하는 약물 조성물, 독소루비신 함유 약물 및 그 제조 방법
CN110960542B (zh) * 2018-09-30 2022-07-26 百药智达（北京）纳米生物技术有限公司 含吡柔比星的药物、其制备方法、药物组合物及其应用
CN110960530B (zh) * 2018-09-30 2022-07-22 百药智达（北京）纳米生物技术有限公司 含他克林的药物、其制备方法、药物组合物及其应用
CN110960534B (zh) * 2018-09-30 2022-07-26 百药智达（北京）纳米生物技术有限公司 含五氟尿嘧啶的药物、其制备方法、药物组合物及其应用
CN110960690B (zh) * 2018-09-30 2022-07-22 百药智达（北京）纳米生物技术有限公司 含表柔比星的药物、其制备方法、药物组合物及其应用
CN110960536B (zh) * 2018-09-30 2022-07-26 百药智达（北京）纳米生物技术有限公司 含阿司匹林的药物、其制备方法、药物组合物及应用
CN111053765B (zh) * 2018-10-16 2022-07-26 百药智达（北京）纳米生物技术有限公司 含紫杉醇的药物、其制备方法、药物组合物及应用
CN111068065B (zh) * 2018-10-22 2022-07-26 百药智达（北京）纳米生物技术有限公司 含奥沙利铂的药物、其制备方法、药物组合物及其应用
CN111084887B (zh) * 2018-10-23 2022-07-22 百药智达（北京）纳米生物技术有限公司 含黄酮的药物、其制备方法、药物组合物及应用
CN111096965B (zh) * 2018-10-29 2022-07-26 百药智达（北京）纳米生物技术有限公司 含双氢青蒿素的药物、其制备方法、药物组合物及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012164A1 (en) * 1991-01-10 1992-07-23 New York University Multiply connected, three-dimensional nucleic acid structures
WO1993012244A1 (en) * 1991-12-12 1993-06-24 New York University Construction of geometrical objects from polynucleotides
WO1997041142A1 (en) * 1996-04-26 1997-11-06 New York University Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000813A1 (en) * 1983-08-03 1985-02-28 The Research Foundation Of State University Of New Nucleic acid branched junctions with precisely defined migrational mobility

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012164A1 (en) * 1991-01-10 1992-07-23 New York University Multiply connected, three-dimensional nucleic acid structures
WO1993012244A1 (en) * 1991-12-12 1993-06-24 New York University Construction of geometrical objects from polynucleotides
WO1997041142A1 (en) * 1996-04-26 1997-11-06 New York University Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules

Also Published As

Publication number Publication date
BR0015484A (pt) 2002-07-02
HUP0203914A2 (en) 2003-03-28
CZ20021472A3 (cs) 2002-07-17
EP1228201A1 (en) 2002-08-07
AU2000101A (en) 2001-05-30
JP2003522524A (ja) 2003-07-29
MXPA02004727A (es) 2002-08-30
RU2002113755A (ru) 2004-01-10
NO20022231L (no) 2002-05-10
WO2001036624A1 (en) 2001-05-25
CN1390253A (zh) 2003-01-08
SK6042002A3 (en) 2002-12-03
KR20020059727A (ko) 2002-07-13
PL358811A1 (en) 2004-08-23
NO20022231D0 (no) 2002-05-10
HK1052529A1 (zh) 2003-09-19
CA2391084A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU782880B2 (en) High order nucleic acid based structures
Dong et al. DNA functional materials assembled from branched DNA: design, synthesis, and applications
Ishikawa et al. RNA tectonics (tectoRNA) for RNA nanostructure design and its application in synthetic biology
Keefe et al. Aptamers as therapeutics
AU2009200036B2 (en) Modulators of pharmacological agents
JP2024029136A (ja) Ｄ因子を阻害するための組成物および方法
Xiao et al. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications
US20110275702A1 (en) Novel DNA Nanostructures that Promote Cell-Cell Interaction and Use Thereof
TW201726918A (zh) 抑制lpa之基因表現之組合物及方法
AU2002312059A1 (en) Modulators of pharmacological agents
JP2006516151A (ja) 改良された薬力学的特性を有する多価アプタマー治療剤ならびにそれらの作製方法および使用法
US20120190732A1 (en) Multifunctional Aptamer-Nucleic Acid Nanostructures for Tumor-Targeted Killing
Kopylov et al. Combinatorial chemistry of nucleic acids: SELEX
Nakamura et al. RNA plasticity and selectivity applicable to therapeutics and novel biosensor development
WO2008066621A2 (en) Reversible platelet inhibition
JP5673992B2 (ja) 血管内皮細胞増殖因子結合性アプタマー
CN102171339A (zh) 针对ngf的适体及其用途
Zavyalova et al. DNA aptamer-based molecular nanoconstructions and nanodevices for diagnostics and therapy
ZA200204728B (en) High order nucleic acid based structures.
Nulf et al. DNA assembly using bis-peptide nucleic acids (bisPNAs)
Otte et al. Nucleic Acid Aptamers: From Basic Research to Clinical Applications
JP7264487B2 (ja) キマーゼに対するアプタマー及びその使用
WO2020204151A1 (ja) Ｆｇｆ９に対するアプタマー及びその使用
Eckstein Exogenous application of ribozymes for inhibiting gene expression
Iric Assembly of DNA-encapsulated lipid bilayers and their application to studies of GPCRs